ABSTRACT
Introduction
Granular cell tumor (GCT) is a rare neoplasm of putative Schwann cell origin. Although a variety of organs may be affected with this tumor, it usually appears in the tongue, oral cavity, skin and subcutaneous tissue (1) (2) (3) . Breast is one of the unusual locations for this tumor. Approximately 6% of all cases occur in the breast (4) (5) (6) . Among all breast cancers, on the other hand, GCT has been reported to occur in 0.1% of cases (2, 7) . This entity as a tumor was first described by Abrikossoff (8) in 1926, who attributed its origin to striated muscle cells, and therefore named this tumor as myoblastoma. Subsequently, however, accumulated data from both immunohistochemical and ultrastructural studies have indicated that GCT is derived from peripheral nerve sheath cells (9) . Clinically, GCTs of the breast, because of their firmness and immobility, can easily mimic primary invasive breast cancer. Moreover, on mammography, they can present as ill-defined infiltrative or spiculated lesions, reminiscent of invasive cancer. Therefore, identifying this usually benign tumor and distinguishing it from other malignancies is significant. Herein, we present a rare case of GCT of the breast with associated hyalinized fibroadenoma, florid ductal epithelial hyperplasia and sclerosing adenosis, in a 58 year-old female.
Case report
A 58 year-old female presented with a right breast lump. On physical examination, there was a mass in the lower outer quadrant of the right breast. Ultrasonography revealed a hypoechoic, nonhomogeneous mass lesion. Mammography showed a dense shadow
Discussion
Granular cell tumor is an uncommon, generally benign neoplasm. The most common localization of the tumor is the tongue, that nearly accounts for 30% of all cases, followed by the oral cavity, skin and subcutaneous tissue (1) (2) (3) . Breast is an unusual site for this tumor, accounting for approximately 6% of all cases (1) (2) (3) 5, 6, 9) . It occurs predominantly in women between fourth to sixth decades (1, 4, 9) . Its incidence in the breast is estimated to be 0.1% (2, 4, 7) .
Although originally considered a muscle tumor, its close association with nerve and its schwannian features shown both by immunohistochemical staining and electron microscopy, firmly identifies this lesion as a neural tumor (4) . GCT predominantly affects the upper inner quadrant and less commonly the lower outer quadrant of the breast, in contrast to invasive breast cancer that is mostly localized to the upper outer quadrant. The cause of this predilection is that, these areas are within the territory of distribution of the cutaneous sensory branches of the supraclavicular nerve (1, 4, 10) . The tumor in our patient was localized in the lower outer quadrant of the breast, similar to case reported by Hoess et al. (2) . GCT may mimic invasive breast cancer clinically, radiologically, and even by gross pathologic examination. Clinically, GCT of the breast generally presents as a firm, painless mass that may be partly mobile. Superficial lesions may cause nipple inversion or skin retraction, which makes the differential diagnosis even harder. The ultrasonographic and mammographic features of the tumor can be misleading as well. Radiologic appearance varies from a stellate mass that is difficult to distinguish from a carcinoma to well circumscribed nearly benign appearing mass lesion (10) . On gross examination, the lesion is generally more sharply circumscribed than typical invasive carcinoma. However, the hard consistency and somewhat irregular outline of the tumor necessitates microscopic inspection in order to exclude malignancy. It is therefore impossible to establish a definitive diagnosis of GCT of the breast without a biopsy.
with irregular borders and asymmetric smaller densities nearby, suspicious for malignancy ( Figure 1 ). Magnetic resonance imaging (MRI) revealed a mass lesion, 15x10 mm in size, with regular contours, heterogeneous internal structure and intense contrast enhancement.
Wide local excision of the lesion was performed. On gross examination, the excised specimen was 5.5x4.5x2.5 cm in size. Cut surface of the specimen revealed a yellowish-white, solid mass with ill-defined infiltrating borders that was 8x7 mm in size. The lesion was very close to the anteromedial surgical margin. Microscopically, the lesion was composed of nests and cords of large, round or polyhedral cells with granular, eosinophilic cytoplasm and small central or eccentric nuclei. The infiltrative pattern of these cells among thick collagen bundles was prominent (Figure 2 ). Neither mitotic figures nor pleomorphic cells were observed in the lesion. Immunohistochemical study revealed intense nuclear and cytoplasmic staining for S-100 protein (Figure 3) , and cytoplasmic staining for CD68. The tumor cells did not stain with pancytokeratin. On the basis of morphologic and immunohistochemical staining results, the case was diagnosed as benign granular cell tumor of the breast. Due to positivity of the tumor at the anteromedial surgical margin, re-excision of the breast was performed about one month after the first operation. There was no residual tumor in the re-excision specimen. However, extensive sclerosing adenosis, florid epithelial hyperplasia (Figure 4) , and an incidental hyalinized fibroadenoma were present. The postoperative period was uneventful, and the patient is well and free of disease after 6 months of operation. Malignant GCTs are very rare. They constitute less than 1% of all cases. Currently, histological criteria proposed by Le at al. (14) and Adeniran et al. (15) are being used to discriminate benign from malignant GCT. The presence of necrosis, nuclear pleomorphism, high nuclear/cytoplasmic ratio, vesicular nuclei with large nucleoli, spindling of the cells, and increased mitotic activity (>2 mitoses per 10 HPF at x200 magnification) are evaluated (14, 15) . Histologically, when two of these six criteria are present, the case is diagnosed as atypical GCT. If three or more criteria exists, the lesion is more likely to behave in a malignant fashion. In our case, none of these criteria were present.
The differential diagnosis of GCT is diverse, and includes both benign lesions such as inflammatory fat necrosis and sclerosing adenosis; malignant lesions such as apocrine carcinoma, secretory carcinoma; and metastatic lesions. Pleomorphic lobular carcinoma should also be in the differential diagnosis, because it may show apocrine or histiocytoid differentiation (16) (17) (18) . The most common metastatic tumors that can be confused with GCT are tumors that have oncocytic or clear cell features, such as renal cell carcinoma, malignant melanoma and alveolar soft part sarcoma (4). An immunohistochemical stain for pancytokeratin can be used to highlight the presence of epithelial component in these tumors. Apocrine carcinomas show positive immunostaining with gross cystic disease fluid protein-15 (GCDFP-15) and androgen receptor, as well as epithelial membrane antigen (EMA). Secretory carcinomas, although may show S-100 protein positivity, are also immunoreactive for polyclonal carcinoembryonic antigen (CEA) and α-lactalbumin. Intense nuclear and cytoplasmic staining for S-100 protein and cytoplasmic staining for CD68, in addition to negative staining, with pancytokeratin, supported our diagnosis of GCT, in our case.
In conclusion, we report a case of GCT of the breast with associated florid epithelial hyperplasia, extensive sclerosing adenosis, and an incidental hyalinized fibroadenoma. GCT of the breast, although seen very rarely compared to invasive breast cancer, should always be kept in mind in an infiltrative lesion composed of cells with eosinophilic granular cytoplasm. Diagnosis of GCT would prevent unnecessary additional treatment modalities. 
